ALK is a global healthcare company that has been dedicated to improving the lives of people with allergies since 1923. With operations in 46 countries and more than 2.4 million people using its products worldwide, ALK is a leading name in the field of allergy treatment and care.
Allergy is a global health issue, and ALK is committed to addressing it through long-term solutions that go beyond symptom relief. The company works to improve the everyday lives of those living with poorly controlled allergies by providing support, treatment options, and resources that make a meaningful difference.
Driven by a strong culture of innovation and responsibility, ALK continues to invest in research, partnerships, and new approaches to allergy care. Strategic collaborations across Asia-Pacific and other regions are helping the company expand access to its treatments and reach more people in need.
Owned by the Lundbeck Foundation and celebrating over 100 years of history, ALK combines scientific expertise with a people-first mindset. From its origins in Denmark to its global presence today, ALK continues to evolve as a trusted partner for patients, families, and healthcare professionals around the world.